Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Appointments

Set Alert for Appointments

Executives On The Move: Eisai Taps Celgene And Sanofi VPs For Its Team, And Freeline Selects A CEO

Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.

Appointments BioPharmaceutical

Ex-Janssen India Chief To Lead PE-Controlled Bharat Serums

Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.

Commercial Appointments

Executives On The Move: Exits From Takeda Vaccines And Novartis Institutes To CMO Positions And Board Changes At Merck & Co.

Takeda Vaccines VP switches to cancer immunotherapy and vaccine company Bavarian Nordic and Novartis Institutes exec moves to molecular medicines firm Boston Pharmaceuticals, each in the CMO position. Meanwhile, Merck & Co will add a scientific and a strategic expert to its board.

 

Appointments BioPharmaceutical

Executives On The Move: Bayer Names Upcoming Information Chief And Legal Hires At Eli Lilly And CytoDyn

Stryker tech officer will become Bayer AG’s chief information technology and digital transformation Officer in June. In addition, monoclonal antibody therapy firm CytoDyn and global pharma Eli Lilly each hire a general counsel.

Appointments BioPharmaceutical

Freeline Bags Alnylam's Heggie As CEO

Syncona-backed Freeline has nabbed an "accomplished commercial leader" in Theresa Heggie to lead the company as it prepares to take FLT180a, its gene therapy for hemophilia B, into Phase III.

Blood & Coagulation Disorders Gene Therapy

Cipla Rejigs Executives, New Chief For North America Business

Ex-Torrent COO Arunesh Verma to lead Cipla’s North America generics business, while the head of Cipla USA has been repositioned to lead the India prescription business, among other personnel changes.

Appointments India

Executives On The Move: Gamida Cell Decides On Regulatory Appointment, Twist Bio Announces A Promotion And A VP Leaves Sanofi Genzyme For Krystal Biotech

Cellular and immune therapeutics company Gamida Cell has a new chief regulatory and quality officer and the SVP, R&D at Twist Biosciences steps higher to the chief operating officer position. At Sanofi Genzyme a genetic diseases VP leaves to become chief commercial officer at Krystal Biotech.

Appointments BioPharmaceutical

Hilleman CEO Moving On, Hands Baton To Ex-Takeda Executive

Hilleman CEO Davinder Gill is leaving the global vaccine R&D organization after eight years at the helm and several mileposts. Incoming CEO Raman Rao takes charge from 1 February.

Commercial Appointments

Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine

Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.

Appointments BioPharmaceutical

Executives On The Move: BD Moves From Roche And BMS To Compugen And Turnstone

A Roche director joins predictive drug discovery firm Compugen and a Bristol-Myers Squibb exec is welcomed at immuno-oncology company Turnstone Biologics – both in Business Development. And China- and US-based biopharma Antegene brings on Celgene manager as CBO.

Appointments

Executives On The Move: Departures At Ipsen And Novo Nordisk And A Board Change At PDL BioPharma

The CEO of Ipsen Group departs to take top job at new gene therapy company FerGene and Novo Nordisk’s VP, regulatory affairs moves to EVP, quality and regulatory at Scandinavian orthobiologics firm BoneSupport. At commercial-stage pharma business PDL BioPharma, a chairperson is elected.

Appointments BioPharmaceutical

Executives On The Move: Five New CEOs Announced

New CEOs for Abgenomics, Advangen, Dynavax Technologies, Merus and Nuvelution are among the latest biopharma appointments. Kiadis Pharma’s CFO’s resignation takes effect on 31 December.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register